Dorchester Wealth Management CO Abb Vie Inc. Transaction History

Dorchester Wealth Management CO

$531 Million
Q2 2024

A detailed history of Dorchester Wealth Management CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Dorchester Wealth Management CO holds 5,255 shares of ABBV stock, worth $1.04 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

5,255

Previous 6,405 17.95%

Holding current value

$1.04 Million

Previous $1.17 Million 22.73%

% of portfolio

0.17%

Previous 0.21%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	SELL	$154.79 - $180.76 $178,008 - $207,874	-1,150 Reduced 17.95%	5,255 $901,000
Q1 2024 Apr 30, 2024	SELL	$159.82 - $182.1 $143,838 - $163,890	-900 Reduced 12.32%	6,405 $1.17 Million
Q4 2023 Jan 23, 2024	BUY	$137.6 - $154.97 $51,324 - $57,803	373 Added 5.38%	7,305 $1.13 Million
Q3 2023 Oct 24, 2023	SELL	$133.59 - $154.65 $50,096 - $57,993	-375 Reduced 5.13%	6,932 $1.03 Million
Q2 2023 Jul 13, 2023	SELL	$132.51 - $164.9 $33,127 - $41,225	-250 Reduced 3.31%	7,307 $984,000
Q1 2023 Apr 26, 2023	BUY	$144.61 - $166.54 $836,135 - $962,934	5,782 Added 325.75%	7,557 $1.2 Million
Q4 2022 Jan 31, 2023	SELL	$138.31 - $165.87 $716,722 - $859,538	-5,182 Reduced 74.49%	1,775 $287,000
Q3 2022 Oct 24, 2022	SELL	$134.21 - $153.93 $87,236 - $100,054	-650 Reduced 8.54%	6,957 $934,000
Q2 2022 Aug 04, 2022	BUY	$137.62 - $174.96 $333,040 - $423,403	2,420 Added 46.66%	7,607 $1.17 Million
Q1 2022 May 10, 2022	SELL	$131.98 - $163.75 $79,188 - $98,250	-600 Reduced 10.37%	5,187 $1.05 Million
Q4 2021 Feb 08, 2022	SELL	$107.43 - $135.93 $53,715 - $67,965	-500 Reduced 7.95%	5,787 $784,000
Q3 2021 Oct 26, 2021	SELL	$106.4 - $120.78 $21,280 - $24,156	-200 Reduced 3.08%	6,287 $678,000
Q2 2021 Jul 22, 2021	SELL	$105.21 - $117.21 $5,050 - $5,626	-48 Reduced 0.73%	6,487 $731,000
Q3 2020 Oct 19, 2020	SELL	$85.91 - $100.83 $8,591 - $10,083	-100 Reduced 1.51%	6,535 $572,000
Q2 2020 Jul 20, 2020	SELL	$73.37 - $98.18 $29,348 - $39,272	-400 Reduced 5.69%	6,635 $651,000
Q3 2019 Oct 18, 2019	SELL	$62.98 - $75.72 $9,447 - $11,358	-150 Reduced 2.09%	7,035 $533,000
Q2 2019 Jul 19, 2019	SELL	$65.7 - $83.98 $102,360 - $130,840	-1,558 Reduced 17.82%	7,185 $522,000
Q1 2019 Apr 17, 2019	SELL	$77.14 - $90.79 $46,206 - $54,383	-599 Reduced 6.41%	8,743 $705,000
Q2 2018 Jul 17, 2018	SELL	$89.78 - $106.23 $8,978 - $10,623	-100 Reduced 1.06%	9,342 $866,000
Q1 2018 Apr 20, 2018	SELL	$92.01 - $123.21 $27,603 - $36,963	-300 Reduced 3.08%	9,442 $894,000
Q4 2017 Jan 18, 2018	SELL	$89.56 - $98.21 $8,956 - $9,821	-100 Reduced 1.02%	9,742 $942,000
Q3 2017 Oct 19, 2017	BUY	$69.85 - $89.22 $687,463 - $878,103	9,842	9,842 $875,000

Others Institutions Holding ABBV

# of Institutions

3,695

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $349B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dorchester Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Dorchester Wealth Management CO with notifications on news.

Account

Dorchester Wealth Management CO Abb Vie Inc. Transaction History